New Novartis data in relapsing MS reinforce benefits of Kesimpta® for first-line and switch patients
Sep 18, 2024 East Hanover, September 18, 2024 – Novartis today announced new data from the ALITHIOS open-label extension study. Data…
7 Tips for Talking with Friends and Family About Your Chronic Illness
Photography by Julia Forsman/Stocksy United Letting your loved ones know about your symptoms, triggers, and boundaries can help them better…
Stuart Schlossman
Battling the Dark Clouds of Depression When Living with MS
An Empowered Spirit Blog Post – Written by Cathy Chester on September 9, 2024 A decade ago, I wrote a blog post about…
Stuart Schlossman
What to Know About Neuropathic Pain (and How to Manage It)
Neuropathic pain is not your average pain. Here’s what to know about this unique type of MS pain and how…
Stuart Schlossman
video presentation Defining the “Pathways to Cures Roadmap” with global collaboration
The Printed version of this video can be read by clicking here…
Stuart Schlossman
video: AGING and Multiple Sclerosis
August 2024 – Presented by Aaron Boster, MD A look at how we Age with Multiple Sclerosis. Are the symptoms…
Stuart Schlossman
Managing Fatigue in MS and Pain Management
No excerpt…
Stuart Schlossman
Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to show reduction in disability accumulation in non-relapsing secondary progressive multiple sclerosis
September 2, 2024 • In the HERCULES study, tolebrutinib met the primary endpoint in delaying time to onset of confirmed…
Stuart Schlossman
Why BOTHER taking MS Medications?
No excerpt…
Stuart Schlossman
Medical Cannabis (drug) and Multiple Sclerosis: What does Science Say?
In this video Dr. Boster discusses Medical Cannabis (drugs) and Multiple Sclerosis. It was recorded during a live CME presentation…
Stuart Schlossman
